Cynosure Health is once again thrilled to be supporting the Health Research & Educational Trust (HRET) with its two-year Hospital Improvement Innovation Network (HIIN) contract (with an optional third year based on performance), to continue efforts to reduce hospital-acquired conditions and readmissions.

Results/Intended Results:

The HRET HIIN will align, accelerate, and amplify the prior HRET HEN and Quality Improvement Network-Quality Improvement Organizations (QIN-QIO) successes to pursue the ambitious new goals of reducing all-cause inpatient harm by 20 percent and readmissions by 12 percent by 2019.


HIIN provides technical assistance, educational opportunities, training, resources, and learning collaboratives in the following target areas to help achieve this goal:

  • Adverse Drug Event (ADE)
  • Airway Safety*
  • Catheter-Associated Urinary Tract Infection (CAUTI)
  • Central Line-Associated Bloodstream Infection (CLABSI)
  • Clostridium difficile Infection (CDI)*
  • Culture of Safety*
  • Diagnostic Errors*
  • Injuries from Falls and Immobility
  • Health Care Disparities*
  • Iatrogenic Delirium*
  • Malnutrition in the Inpatient Setting
  • Multi-Drug Resistant Organisms* (such as VRE – Vancomycin-resistant enterococcus, CRE-Carbapenem-resistant enterobacteriaceae, and MRSA- Methicillin-resistant Staphylococcus aureus)
  • Patient and Family Engagement (PFE)*
  • Pressure Ulcers/Injuries (PrU)
  • Radiation Exposure*
  • Readmissions
  • Sepsis*
  • Surgical Site Infection (SSI)
  • Venous Thromboembolism (VTE)
  • Ventilator-Associated Event (VAE)

*denotes additional harm topics HIINs may consider

Click here for more information about Partnership for Patients.

Click here for more information about AHA-HRET HIIN.